Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. (Q40282936)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 May 2006

Language	Label	Description	Also known as
English	Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.	scientific article published on 6 May 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Shigeru Morikawa

5

object named as

Shigeru Morikawa

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tetsuya Mizutani

4

object named as

Tetsuya Mizutani

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hideki Hasegawa

2

object named as

Hideki Hasegawa

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

object named as

Noriyo Nagata

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

object named as

Koji Ishii

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

6

object named as

Tetsuro Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Fumihiro Taguchi

7

object named as

Fumihiro Taguchi

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Toshitada Takemori

9

object named as

Toshitada Takemori

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tatsuo Miyamura

10

object named as

Tatsuo Miyamura

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yasuko Tsunetsugu-Yokota

11

object named as

Yasuko Tsunetsugu-Yokota

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Masato Tashiro

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

6 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

351

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

368-380

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Effects of a SARS-associated coronavirus vaccine in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

SARS coronavirus: a new challenge for prevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Immunogenicity of an Attenuated Strain of Vaccinia Virus on Rabbits and Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

The Genome sequence of the SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Advances in mucosal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A new mutant of dermovaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Oligomerization of a membrane protein correlates with its retention in the Golgi complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

The SARS-CoV S glycoprotein: expression and functional characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Production and immunogenicity of multiple antigenic peptide (MAP) constructs derived from the S1 glycoprotein of infectious bronchitis virus (IBV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

based on heuristic

inferred from DOI database lookup

The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16678878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment and vaccines for severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16678878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16678878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIROL.2006.03.020

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40282936&oldid=1772412828"